1. Home
  2. Stock quotes
  3. Cogent Biosciences
  4. Financial Statements
Cogent Biosciences logo
Cogent Biosciences COGT
$ 7.81 0.06%
mail-toReport an Error

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Cogent Biosciences Financial Statements 2011-2024 | COGT

Annual Financial Statements Cogent Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

 597 M 764 M 230 M 17.5 M 22.9 M 98.6 M 22.8 M 22.5 M - - - - -

Shares

 79.7 M 58.7 M 38.7 M 2 M 7.62 M 6.22 M 5.86 M 5.86 M - - - - -

Historical Prices

 7.5 13 5.93 7.84 2.68 17 - - - - - - -

Net Income

 -192 M -140 M -72.3 M -74.8 M -31.8 M -34.5 M -25.5 M -18.1 M -6.59 M - - - -

Revenue

 - - - 7.87 M 22.5 M 9.73 M 8.36 M 6.36 M 2.99 M - - - -

Cost of Revenue

 - - - - - - - - - - - - -

Gross Profit

 - - - 7.87 K - - - - - - - - -

Operating Income

 -208 M -148 M -75.6 M -82.2 M -32.2 M -36 M -26.2 M - - - - - -

Interest Expense

 - - - - 78 K 320 K 274 K - - - - - -

EBITDA

 -206 M -147 M -75.4 M -81.5 M -30.9 M -34.7 M -25 M -18.2 M -6.41 M - - - -

Operating Expenses

 - - - 90.1 M - - - - - - - - -

General and Administrative Expenses

 34.4 M 26.2 M 19.6 M 17.4 M 11 M 7.45 M 4.68 M 3.43 M 2.73 M - - - -

All numbers in USD currency

Quarterly Income Statement Cogent Biosciences

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

 110 M 99.2 M 94.8 M 86.1 M 86.2 M 74.8 M 70.7 M 69.9 M 69.6 M 49.4 M 45.1 M 43.8 M 39.8 M 38.4 M 34.9 M 32.3 M 9.85 M 7.78 M 7.53 M 30.7 B 30.7 B 30.5 B 30.1 B 30 B 29.9 B 29.2 B 10.2 B 10.2 M 10.2 M 10.2 M 10.2 M - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

 -70.6 M -59 M -58.3 M - -55.4 M -44.1 M -38.6 M - -35.1 M -34.9 M -30.6 M - -19.1 M -16.5 M -11.7 M - -50 M -7.39 M -6.09 M 2.3 M -11.9 M -10.5 M -11.7 M -8.61 M -34.5 M -34.5 M -34.5 M -6.69 M -7 M -5.86 M 25.5 M - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

 - - - - - - - - - - - - - - - - 312 K 528 K 7.03 M 15.3 M 1.02 M 3.14 M 3.05 M 3.8 M 2.04 M 1.67 M 2.22 M 2.12 M 2.33 M 2.08 M 1.83 M - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

 -75.4 M -64.4 M -62.4 M - -59.6 M -47.1 M -43.2 M - -36.8 M -35.9 M -31.4 M - -19.8 M -17.3 M -12.8 M - -57.2 M -7.4 M -6.14 M 2.24 M -12 M -10.5 M -11.8 M -9 M -10.6 M -9.44 M -6.99 M -6.88 M -7.17 M -6.03 M -6.07 M - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

 1 K 44 K -1 K - - 268 K 682 K - - - - - - - - - - 7 K - - 82 K - - - 3 K 157 K 170 K - 70 K 73 K - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

 - - -61.8 M - - - -42.7 M - -36.4 M -35.7 M -31.3 M - -19.7 M -17.3 M -12.8 M - -56.5 M -6.82 M -5.85 M 2.24 M -11.1 M -9.88 M -11.5 M -9 M -9.61 M -8.8 M -6.67 M -6.88 M -6.31 M -5.47 M -5.79 M - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

 11.8 M 10.1 M 9.7 M - 9.45 M 8.21 M 7.2 M - 6.88 M 6.38 M 5.95 M - 5.02 M 4.9 M 4.59 M - 5.6 M 2.8 M 3.67 M - 2.72 M 3.06 M 2.49 M - 2.37 M 1.98 M 1.06 M - 1.32 M 971 K 944 K - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency